Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study (Q73645071)
scientific article published on 01 March 2000
Language:
(P31) (Q13442814)
(P304) 111-117
(P407) (Q1860)
(P433) 2
(P478) 89
(P577) Wednesday, March 1, 2000
(P921) (Q12859063)
(Q277954)
(Q412178)
(P1433) (Q332492)
(P1476) "Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study" (language: en)
(P2093) R M Elledge
S Green
R Pugh
D C Allred
G M Clark
J Hill
P Ravdin
S Martino
C K Osborne
other details
description scientific article published on 01 March 2000

External Links